Back to Search Start Over

Subcutaneous defibrillators for dialysis patients

Authors :
Roy O. Mathew
Tushar J. Vachharajani
Dawn Calderon
Arif Asif
Sushil K. Mehandru
Eric J. Costanzo
Mandeep S. Sidhu
Loay Salman
Mayurkumar Patel
Source :
Hemodialysis International. 22:4-8
Publication Year :
2017
Publisher :
Wiley, 2017.

Abstract

Defibrillation can be successfully provided by the subcutaneous implantable cardioverter defibrillator (ICD) without the leads. In contrast, traditional ICDs require leads that can cause central venous stenosis, lead-induced endocarditis, and carry the risk of tricuspid regurgitation by valve adhesion, perforation, coaptation interference, or entanglement. Central venous stenosis, infection, and tricuspid regurgitation are all critically important considerations in hemodialysis patients. Recent reports are supporting the use of subcutaneous ICDs in renal patients maintained on long-term hemodialysis. This article provides the risks associated with leads of traditional defibrillators and raises awareness of the subcutaneous ICD and their benefits for hemodialysis patients.

Details

ISSN :
14927535
Volume :
22
Database :
OpenAIRE
Journal :
Hemodialysis International
Accession number :
edsair.doi...........e172b32cbb433b8c590063cf7255ca26
Full Text :
https://doi.org/10.1111/hdi.12577